172 related articles for article (PubMed ID: 15539635)
1. Physiological growth synergizes with pathological genes in experimental cardiomyopathy.
Syed F; Odley A; Hahn HS; Brunskill EW; Lynch RA; Marreez Y; Sanbe A; Robbins J; Dorn GW
Circ Res; 2004 Dec; 95(12):1200-6. PubMed ID: 15539635
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy.
Yussman MG; Toyokawa T; Odley A; Lynch RA; Wu G; Colbert MC; Aronow BJ; Lorenz JN; Dorn GW
Nat Med; 2002 Jul; 8(7):725-30. PubMed ID: 12053174
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
[TBL] [Abstract][Full Text] [Related]
4. A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular non-compaction in humans, results in left ventricular hypertrophy that progresses to dilation in a mouse model.
Kaneda T; Naruse C; Kawashima A; Fujino N; Oshima T; Namura M; Nunoda S; Mori S; Konno T; Ino H; Yamagishi M; Asano M
Clin Sci (Lond); 2008 Mar; 114(6):431-40. PubMed ID: 17956225
[TBL] [Abstract][Full Text] [Related]
5. Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function.
Funakoshi H; Chan TO; Good JC; Libonati JR; Piuhola J; Chen X; MacDonnell SM; Lee LL; Herrmann DE; Zhang J; Martini J; Palmer TM; Sanbe A; Robbins J; Houser SR; Koch WJ; Feldman AM
Circulation; 2006 Nov; 114(21):2240-50. PubMed ID: 17088462
[TBL] [Abstract][Full Text] [Related]
6. Adrenergic pathways and left ventricular remodeling.
Dorn GW
J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
[TBL] [Abstract][Full Text] [Related]
7. Distinct functions of junD in cardiac hypertrophy and heart failure.
Ricci R; Eriksson U; Oudit GY; Eferl R; Akhmedov A; Sumara I; Sumara G; Kassiri Z; David JP; Bakiri L; Sasse B; Idarraga MH; Rath M; Kurz D; Theussl HC; Perriard JC; Backx P; Penninger JM; Wagner EF
Genes Dev; 2005 Jan; 19(2):208-13. PubMed ID: 15655111
[TBL] [Abstract][Full Text] [Related]
8. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
[TBL] [Abstract][Full Text] [Related]
9. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes.
Wettschureck N; Rütten H; Zywietz A; Gehring D; Wilkie TM; Chen J; Chien KR; Offermanns S
Nat Med; 2001 Nov; 7(11):1236-40. PubMed ID: 11689889
[TBL] [Abstract][Full Text] [Related]
10. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy.
Khoo MS; Li J; Singh MV; Yang Y; Kannankeril P; Wu Y; Grueter CE; Guan X; Oddis CV; Zhang R; Mendes L; Ni G; Madu EC; Yang J; Bass M; Gomez RJ; Wadzinski BE; Olson EN; Colbran RJ; Anderson ME
Circulation; 2006 Sep; 114(13):1352-9. PubMed ID: 16982937
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile in dilated cardiomyopathy caused by elevated frequencies of mitochondrial DNA mutations in the mouse heart.
Zhang D; Ezekiel UR; Chang SW; Zassenhaus HP
Cardiovasc Pathol; 2005; 14(2):61-9. PubMed ID: 15780797
[TBL] [Abstract][Full Text] [Related]
12. Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha(q): lack of correlation between phospholipase C activation and the phenotype.
Mende U; Semsarian C; Martins DC; Kagen A; Duffy C; Schoen FJ; Neer EJ
J Mol Cell Cardiol; 2001 Aug; 33(8):1477-91. PubMed ID: 11448136
[TBL] [Abstract][Full Text] [Related]
13. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
Chiu HC; Kovacs A; Blanton RM; Han X; Courtois M; Weinheimer CJ; Yamada KA; Brunet S; Xu H; Nerbonne JM; Welch MJ; Fettig NM; Sharp TL; Sambandam N; Olson KM; Ory DS; Schaffer JE
Circ Res; 2005 Feb; 96(2):225-33. PubMed ID: 15618539
[TBL] [Abstract][Full Text] [Related]
14. Pressure overload causes cardiac hypertrophy in beta1-adrenergic and beta2-adrenergic receptor double knockout mice.
Palazzesi S; Musumeci M; Catalano L; Patrizio M; Stati T; Michienzi S; Di Certo MG; Mattei E; Vitelli L; Marano G
J Hypertens; 2006 Mar; 24(3):563-71. PubMed ID: 16467660
[TBL] [Abstract][Full Text] [Related]
15. Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44).
Edes IF; Tóth A; Csányi G; Lomnicka M; Chłopicki S; Edes I; Papp Z
J Mol Cell Cardiol; 2008 Sep; 45(3):363-72. PubMed ID: 18674539
[TBL] [Abstract][Full Text] [Related]
16. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload.
Rogers JH; Tamirisa P; Kovacs A; Weinheimer C; Courtois M; Blumer KJ; Kelly DP; Muslin AJ
J Clin Invest; 1999 Sep; 104(5):567-76. PubMed ID: 10487771
[TBL] [Abstract][Full Text] [Related]
17. Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart.
Hilfiker-Kleiner D; Hilfiker A; Kaminski K; Schaefer A; Park JK; Michel K; Quint A; Yaniv M; Weitzman JB; Drexler H
Circulation; 2005 Sep; 112(10):1470-7. PubMed ID: 16129800
[TBL] [Abstract][Full Text] [Related]
18. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans.
Frey UH; Lieb W; Erdmann J; Savidou D; Heusch G; Leineweber K; Jakob H; Hense HW; Löwel H; Brockmeyer NH; Schunkert H; Siffert W
Eur Heart J; 2008 Apr; 29(7):888-97. PubMed ID: 18326504
[TBL] [Abstract][Full Text] [Related]
20. p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload.
Nishida K; Yamaguchi O; Hirotani S; Hikoso S; Higuchi Y; Watanabe T; Takeda T; Osuka S; Morita T; Kondoh G; Uno Y; Kashiwase K; Taniike M; Nakai A; Matsumura Y; Miyazaki J; Sudo T; Hongo K; Kusakari Y; Kurihara S; Chien KR; Takeda J; Hori M; Otsu K
Mol Cell Biol; 2004 Dec; 24(24):10611-20. PubMed ID: 15572667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
